Centre for Child Health Research, Tampere University and Tampere University Hospital, Kalevantie 4, 33014 Tampereen yliopisto, Tampere, Finland.
Terveystalo Healthcare, Tampere, Finland.
Eur J Pediatr. 2021 Oct;180(10):3101-3109. doi: 10.1007/s00431-021-04074-3. Epub 2021 Apr 20.
Our aim was to synthesize the published literature on factors that potentially affect the delivery of bronchodilators using valved holding chambers (VHC) in preschool children. We also aimed to identify those attributes that are not yet incorporated or clearly stated in the guidelines and those topics that are still lacking sufficient data. There is strong evidence supporting several recommendations in current guidelines. Based on present knowledge, bronchodilators should be delivered by VHC administering each puff separately. Face mask should be omitted as soon as the child can hold the mouthpiece of the VHC tightly between the lips and teeth. Based on the review, we suggest adding a specific note to current guidelines about the effect of chamber volume and the impact of co-operation during drug administration. Calming the child and securing a tight face-to-mask seal is critical for successful drug delivery. There is not enough evidence to make specific recommendations on the most reliable VHC and face mask for children. There is an urgent need for studies that evaluate and compare the effectiveness of VHCs in various clinical settings in wide age-groups and respiratory patterns. In addition, there is insufficient data on ideal chamber volume, material, and effective antistatic treatment. What is Known: • Valved holding chambers (VHC) should not be considered interchangeable when used with pressurized metered dose inhalers (pMDI). • Drug delivery is influenced by VHC volume, aerodynamic and electrostatic properties; mask fit; respiratory pattern and co-operation during inhalation; and the number of puffs actuated. What is New: • The impact of co-operation, VHC volume, and good mask-to-face fit during drug inhalation is not stressed enough in the guidelines. • Studies are urgently needed to evaluate the effectiveness of different VHCs in various clinical settings focusing on VHC electrostatic properties, respiratory patters, face masks, and ideal pMDI+VHC combinations.
我们的目的是综合已发表的文献,以探讨影响学龄前儿童使用带阀式储雾罐(VHC)吸入支气管扩张剂的相关因素。我们还旨在确定那些尚未纳入或在指南中未明确规定的特性,以及那些仍缺乏足够数据的主题。目前的指南有大量证据支持其中的一些建议。根据现有知识,应通过 VHC 逐个喷药来输送支气管扩张剂。只要儿童能够将 VHC 的吸嘴紧紧地含在嘴唇和牙齿之间,就应省略面罩。根据本次综述,我们建议在现行指南中添加一个特定注释,说明储雾罐体积的影响以及药物输送过程中的合作情况。使儿童保持镇静并确保面罩与面部紧密贴合对于成功输送药物至关重要。目前尚无足够证据来制定关于最可靠的 VHC 和儿童面罩的具体建议。迫切需要开展研究,以评估和比较各种临床环境中不同年龄组和呼吸模式下 VHC 的有效性。此外,关于理想的储雾罐体积、材料和有效的抗静电处理,目前的数据还不够充分。已知内容:• 带阀式储雾罐(VHC)与压力定量吸入器(pMDI)一起使用时,不应被视为可互换。• VHC 体积、空气动力学和静电特性、面罩适配、呼吸模式、吸入过程中的配合以及激活的喷药次数都会影响药物输送。新内容:• 指南中对药物吸入过程中的合作、VHC 体积和良好的面罩贴合的影响强调得还不够。• 迫切需要开展研究,以评估不同 VHC 在各种临床环境中的有效性,重点关注 VHC 的静电特性、呼吸模式、面罩和理想的 pMDI+VHC 组合。